Suchergebnisse - "Young, Guy"

PubPharm (13)

1

Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors

enthalten in: Expert review of hematology | 2023

von Pipe, S. | Dunn, A. | Young, G.

2

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2022

von Pipe, S. | Hermans, C. | Chitlur, M. | +28

3

The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2021

von Escobar, M. | Castaman, G. | Boix, S. | +27

4

Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting : A review of clinical studies and registries

enthalten in: American journal of hematology | 2017

von Young, G. | Escobar, M. | Pipe, S. | +1

5

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

enthalten in: The New England journal of medicine | 2017

von Oldenburg, J. | Mahlangu, J. | Kim, B. | +12

CommentIn: J Pediatr. 2017 Nov;190:287-290. - PMID 29144254

6

Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity

enthalten in: Journal of thrombosis and haemostasis : JTH | 2015

von Mahlangu, J. | Weldingh, K. | Lentz, S. | +40

7

Evaluation of algorithms for the treatment of problem bleeding episodes in patients with hemophilia having inhibitors

enthalten in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis | 2015

von Young, G. | Teitel, J. | d'Oiron, R. | +2

8

40K glycoPEGylated, recombinant FVIIa : 3-month, double-blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors

enthalten in: Journal of thrombosis and haemostasis : JTH | 2013

von Ljung, R. | Karim, F. | Saxena, K. | +26

9

PRO-PACT : retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors

enthalten in: Thrombosis research | 2012

von Young, G. | Auerswald, G. | Jimenez-Yuste, V. | +4

10

Off-label use of rFVIIa in children with excessive bleeding : a consecutive study of 153 off-label uses in 139 children

enthalten in: Pediatric blood & cancer | 2009

von Young, G. | Wicklund, B. | Neff, P. | +2